Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(30 sites)
Australia
Coffs Habour Health Campus - NCCI, Coffs Harbour, New South Wales Calvary Mater Newcastle Hospital, Waratah, New South Wales Westmead Hospital, Westmead, New South Wales Sunshine Coast University Hospital, Birtinya, Queensland Cairns Hospital, Cairns, Queensland Gold Coast University Hospital, Southport, Queensland The Queen Elizabeth Hospital, Woodville, South A. Monash Medical Centre, Clayton, Victoria Alfred Hospital, Melbourne, Victoria Mildura Base Public Hospital, Mildura, Victoria Royal Brisbane and Womens Hospital, Herston Canada
Cross Cancer Institute, Edmonton, Alberta BCCA - Surrey, Surrey, British Columbia BCCA - Vancouver, Vancouver, British Columbia BCCA - Victoria, Victoria, British Columbia Horizon Health Network, Fredericton, New Brunswick Royal Victoria Regional Health Centre, Barrie, Ontario Health Sciences North, Greater Sudbury, Ontario Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario Kingston Health Sciences Centre, Kingston, Ontario Waterloo Regional Health Network (WRHN), Kitchener, Ontario London Health Sciences Centre Research Inc., London, Ontario Trillium Health Partners - Credit Valley Hospital, Mississauga, Ontario Lakeridge Health Oshawa, Oshawa, Ontario Ottawa Hospital Research Institute, Ottawa, Ontario
Odette Cancer Centre, Toronto, Ontario University Health Network, Toronto, Ontario The Research Institute of the McGill University, Montreal, Quebec Allan Blair Cancer Centre, Regina, Saskatchewan Saskatoon Cancer Centre, Saskatoon, Saskatchewan